Seven studies provided effective clinicopathological characteristics and conducted a detailed quantitative analysis.[10,11,15,17–20] The statistical results indicated that there was no association between the expression level of CASC11 and age, sex, tumor size, or lymph node metastasis. The gene discussed is CASC11; the disease is metastatic malignant neoplasm in the lymph nodes.